Alkem Laboratories Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Alkem Laboratories Ltd. from all sources in a single place.

Load latest

Alkem Laboratories Ltd.

15 Mar 2025

4805.00

-0.17%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

BSE India

In continuation of our earlier intimation dated 07th February, 2025, we wish to inform you that today i.e. 15th March, 2025, a share purchase and share subscription agreement has been executed, inter alios, amongst Alkem Medtech and Bombay Ortho.

pdf

Alkem Laboratories Ltd.

13 Mar 2025

4805.00

-0.17%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

This is to inform you that US FDA had conducted a Bioresearch Monitoring (BIMO) inspection at the Company''s Bioequivalence Centre located at Taloja, Maharashtra from 10th March, 2025 to 13th March, 2025. Kindly take the same on record.

pdf

Alkem Laboratories Ltd.

12 Mar 2025

4805.00

-0.17%

Key diabetes drug price crashes up to 90% as generic versions launched

Business Standard

Mankind, Alkem, Glenmark launch generic versions of empagliflozin

Alkem Laboratories Ltd. is trading below all available SMAs

Alkem Laboratories Ltd.

12 Mar 2025

4805.00

-0.17%

Alkem launches low-cost diabetes drug in Indian market

Business Line

The company is introducing several combination therapies including Empanorm L (empagliflozin and linagliptin), Empanorm Duo and Alsita E (empagliflozin and sitagliptin), and Empanorm M (empagliflozin and metformin)

Number of FII/FPI investors increased from 524 to 535 in Mar 2025 qtr.

Alkem Laboratories Ltd.

12 Mar 2025

4805.00

-0.17%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

This is to inform you that the Company launches generic empagliflozin and its combinations in India under the brand name "Empanorm". A press release in this regard is enclosed herewith. Kindly take the same on record.

pdf

Alkem Laboratories Ltd.

10 Mar 2025

4805.00

-0.17%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

This is to inform you that Mr. Shirish Purushotham Ambulgekar has been appointed at the senior management position of the Company w.e.f. 10th March, 2025.

pdf

Alkem Laboratories Ltd.

10 Mar 2025

4805.00

-0.17%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Please find enclosed herewith the details of investor meetings scheduled to be held on 17th March, 2025, 18th March, 2025, 19th March, 2025, 24th March, 2025 and 25th March, 2025.

pdf

Alkem Laboratories Ltd.

01 Mar 2025

4805.00

-0.17%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement Under Regulation 30 Of SEBI LODR- Regulatory Order

BSE India

Pursuant to Regulation 30 of SEBI LODR Regulations, and further to our earlier intimation dated 28th December, 2024 this is to inform you that the Company has received further order passed by the statutory authority under the Income-tax Act, 1961. The relevant disclosure is enclosed herewith.

pdf

Alkem Laboratories Ltd.

01 Mar 2025

4805.00

-0.17%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement Under Regulation 30 Of SEBI LODR- Regulatory Order

BSE India

Pursuant to Regulation 30 0f SEBI LODR Regulations, 2015, this is to inform that the Company has received an Order passed by the statutory authority under the Goods and Services Tax Act, 2017. The relevant disclosure is enclosed herewith.

pdf